Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Symptoms and General Pathology

Blood and Lymph Conditions

Breast Neoplasms

Shock

Lymphedema

Lymphatic Diseases

Shockwave

Haytham M Elhafez

to investigate the effectiveness of different dosages of ECSW in the treatment of post mastectomy lymphedema volume and quality of life (Qol)

The treatment program included two sessions per week for eight weeks. This study was approved by the ethical committee faculty of Physical Therapy Cairo University. All patients signed a consent form involves their agreement to participate in this study.

Different Level of ECSWT in Post Mastectomy Lymphedema

Different Levels of Energy of Extracorporeal Shock Wave Therapy in Post Masrectomy Lymphedema

Cairo University

Senior Physical Therapist

Nervous System Diseases

Peripheral Nervous System Diseases

Neuromuscular Diseases

Analgesics

All Drugs and Chemicals

Group (A) study group received medical care and standard chemotherapy and shock wave, three times / week for three successful months.

group (B) control group received medical care and standard chemotherapy only.

Shockwave therapy is a multidisciplinary device used in orthopedics, physiotherapy, sports medicine, urology and veterinary medicine. Its main assets are fast pain relief and mobility restoration. Together with being a non-surgical therapy with no need for painkillers makes it an ideal therapy to speed up recovery and cure various indications causing acute or chronic pain. Shockwave is an acoustic wave which carries high energy to painful spots and myoskeletal tissues with sub-acute, sub-chronic and chronic conditions. The energy promotes regeneration and reparative processes of the bones, tendons and other soft tissues. Shockwaves are characterized by jump change in pressure, high amplitude and non-periodicity. The kinetic energy of the projectile, created by compressed air, is transferred to the transmitter at the end of the applicator and further into the tissue.

The Shock wave Therapy.

Mohammed E Ali, Ph.D student

Nehad A. Abo-zaid, Ph.D

Mohammed E. Ali., Ph.D student

This study aimed to assess the efficacy of shock wave in reducing Chemotherapy- Induced Peripheral Neuropathy in adult and pediatric tumors patients.

Peripheral neuropathy is a serious condition characterized by symmetrical, distal damage to the peripheral nerves that may be caused by several classes of drugs, including chemotherapeutic agents. Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect estimated to occur in up to 40% of patients undergoing chemotherapy, with its incidence increasing in patients being treated with multiple agents. Pharmacists play a pivotal role in the prevention and management of CIPN by recommending evidence-based pharmacologic and nonpharmacologic strategies appropriate for the individual patient.Peripheral neuropathy (PN) is a systemic disease characterized by symmetrical, distal damage to the peripheral nerves that negatively impacts patient quality of life (QOL). Prolonged symptoms associated with PN can cause pain, interfere with functional ability (e.g., dressing, driving, house-work), and disrupt emotional health.

Eighty children with tumors were enrolled in this study and were assessed for eligibility. Their aged ranged from eight and forty years. They were assigned randomly into two equal groups. Group (A) study group received the same medical care and shock wave, three times / weak for three successful months. And group (B) control group received medical care and standard chemotherapy only.Nerve conduction studies (NCS) and somatosensory-evoked potentials (SSEPs) were used to assess peripheral neuropathy pre and post intervention. All children were assisted before and after three months of intervention.

Blinding process to participants and care providers was impossible due to the nature of intervention therapy. Data were analyzed by an impartial statistician (outcomes assessor), referring to each arm with an encoded name: Group A (study group) and Group B ( control group).

Effect of Shock Wave In Reducing Chemotherapy- Induced Peripheral Neuropathy In Adult and Pediatric Tumors Patients

Effect of Shock Wave In Reducing Chemotherapy- Induced Peripheral Neuropathy In Adult and Pediatric Tumors Patients:A Randomized Controlled Trail

Malondialdehyde level in blood will be measured

Interlukin 6 (IL-6) level in blood will be measured

Plasma Neurotensin (NT) level in blood will be measured

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Different Level of ECSWT in Post Mastectomy Lymphedema	NCT06278298	Lymphedema of U...	Shockwave CDT	30 Years - 60 Years	Cairo University
Different Level of ECSWT in Post Mastectomy Lymphedema	NCT06278298	Lymphedema of U...	Shockwave CDT	30 Years - 60 Years	Cairo University
Effect of Shock Wave In Reducing Chemotherapy- Induced Peripheral Neuropathy In Adult and Pediatric Tumors Patients	NCT05111730	Peripheral Neur...	The Shock wave ...	8 Years - 40 Years	South Valley University
Effect of Shock Wave In Reducing Chemotherapy- Induced Peripheral Neuropathy In Adult and Pediatric Tumors Patients	NCT05111730	Peripheral Neur...	The Shock wave ...	8 Years - 40 Years	South Valley University

Spots Global Cancer Trial Database for shockwave

Every month we try and update this database with for shockwave cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for shockwave

Every month we try and update this database with for shockwave cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for shockwave cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.